Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Journal of Clinical and Experimental Hematopathology : JCEH|July 1, 2021
A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphomaKazunori Ohnishi, Ken Ohmachi, Kiyoshi Ando, et al.
Leukemia Research|June 1, 2016
Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCTKen Ishiyama, Takuhiro Yamaguchi, Tetsuya Eto, et al.
Transplant Immunology|July 3, 2016
Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignanciesKaori Uchino, Shohei Mizuno, Motonori Mizutani, et al.
Cancer Science|April 7, 2011
Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantationTomoya Hirosawa, Hiroki Torikai, Mayumi Yanagisawa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2015
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working GroupKatsuto Takenaka, Tetsuya Nishida, Yuki Asano-Mori, et al.
Blood Advances|February 8, 2019
High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantationKoichi Miyamura, Takuya Yamashita, Yoshiko Atsuta, et al.
Transplantation and Cellular Therapy|September 22, 2023
Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two DecadesMarie Ohbiki, Yuri Ito, Yoshihiro Inamoto, et al.
International Journal of Hematology|November 27, 2015
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III studyKazuo Muroi, Koichi Miyamura, Masaya Okada, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2016
Comparison of Donor Sources in Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Nationwide Retrospective StudyHirotoshi Sakaguchi, Nobuhiro Watanabe, Kimikazu Matsumoto, et al.
American Journal of Hematology|February 25, 2016
Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or olderTakaaki Konuma, Nobuhiro Tsukada, Junya Kanda, et al.
Pageof 16